Attached files
file | filename |
---|---|
EX-99.2 - EX-99.2 - MEDCATH CORP | g27397exv99w2.htm |
EX-23.1 - EX-23.1 - MEDCATH CORP | g27397exv23w1.htm |
EX-99.1 - EX-99.1 - MEDCATH CORP | g27397exv99w1.htm |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Date of Report (Date of earliest event reported): May 27, 2011
MEDCATH CORPORATION
(Exact name of registrant as specified in its charter)
Delaware (State or other jurisdiction of incorporation or organization) |
000-33009 (Commission File Number) |
56-2248952 (IRS Employer Identification No.) |
10720 Sikes Place
Charlotte, North Carolina 28277
(Address of principal executive offices, including zip code)
Charlotte, North Carolina 28277
(Address of principal executive offices, including zip code)
(704) 708-6600
(Registrants telephone number, including area code)
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13d-4(c)) |
ITEM 2.02 Results of Operations and Financial Condition; 8.01 Other Events
MedCath Corporation (the Company) is filing this Current Report on Form 8-K solely to update
the Companys Annual Report on Form 10-K for the year ended September 30, 2010 (MedCaths 2010
Annual Report) to reflect the reclassification of the historical financial results of TexSAn Heart
Hospital (TSHH) as discontinued operations as a result of the sale of TSHH on December 31, 2010. The results of operations of TSHH were
reclassified to discontinued operations beginning in the first
quarter of fiscal 2011. Such presentation is being provided to
facilitate the comparability of financial information provided in the
proxy statement of the Company as included in the Schedule 14A
(MedCaths 2010 Proxy Statement) filed by the
Company contemporaneously with this Current Report on Form 8-K
and does not include any of the subsequent events or contemplated
transactions discussed in MedCaths 2010 Proxy Statement.
Attached as Exhibit 99.1 to this Current Report on Form 8-K is the updated Item 6: Selected
Financial Data from MedCaths 2010 Annual
Report, which reflects the reclassification of the historical financial results of TSHH as
discontinued operations.
Attached
as Exhibit 99.2 to this Current Report on Form 8-K is the
updated Item 8: Financial Statements and Supplementary Data from
MedCaths 2010 Annual Report, which reflects the
reclassification of the historical financial results of TSHH as
discontinued operations.
The aforementioned reclassification has no effect on the Companys previously reported net
income or net income attributable to MedCath Corporation common stockholders.
ITEM 9.01 Financial Statements and Exhibits
Exhibit | ||
Number | Exhibit | |
23.1
|
Consent of Independent Registered Public Accounting Firm | |
99.1
|
Form 10-K, Item 6. Selected Financial Data | |
99.2
|
Form 10-K, Item 8. Financial Statements and Supplementary Data |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
MEDCATH CORPORATION |
||||
Date: May 27, 2011 | By: | /s/ James A. Parker | ||
James A. Parker | ||||
Executive Vice President and Chief Financial Officer |
EXHIBIT INDEX
Exhibit | ||
Number | Exhibit | |
23.1
|
Consent of Independent Registered Public Accounting Firm | |
99.1
|
Form 10-K, Item 6. Selected Financial Data | |
99.2
|
Form 10-K, Item 8. Financial Statements and Supplementary Data |